07:00 , May 17, 2004 |  BioCentury  |  Finance

U.S. investment in Europe

U.S. investment in Europe Company Country Raised (M) Investors Speedel Switzerland $57.6 Novartis; DSM Venturing Intercell Austria $50.0 Global Life Science Ventures; Apax Partners; Nomura International; TVM Techno Venture Management; NIB; Star Ventures; MPM Capital...
08:00 , Mar 1, 2004 |  BioCentury  |  Finance

Ebb & Flow

Even though the market had expected approval of Genentech's Avastin bevacizumab, that expectation wasn't fully loaded into the stock. DNA was up $12.57 (13%) to $107.89 on the week after Thursday's FDA approval of Avastin...
08:00 , Feb 24, 2004 |  BC Extra  |  Financial News

igeneon raising EUR 26.7 million

Cancer company igeneon (Vienna, Austria) is expected to announce later this week that it has raised EUR 26.7 million ($33.4 million) in a series C round co-led by 3i and Burrill. Other investors included DVC...